For the quarter ending 2025-09-30, OACC made $2,192,321 in revenue. $1,966,742 in net income. Net profit margin of 89.71%.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| General and administrative expenses | 225,579 | 269,810 | ||
| Loss from operations | -225,579 | -269,810 | ||
| Interest earned on cash held in trust account | 2,192,321 | 2,144,153 | ||
| Total other income (expense), net | 2,192,321 | 2,144,153 | ||
| Net income (loss) | 1,966,742 | 1,874,343 | ||
| Earnings per share, basic | 0.08 | - | ||
| Earnings per share, diluted | 0.08 | - | ||
| Weighted average number of shares outstanding, basic | 19,199,029 | - | ||
| Weighted average number of shares outstanding, diluted | 19,199,029 | - | ||
Oaktree Acquisition Corp. III Life Sciences (OACC)
Oaktree Acquisition Corp. III Life Sciences (OACC)